Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021

SELL
$396.76 - $455.92 $1.89 Million - $2.17 Million
-4,768 Closed
0 $0
Q2 2021

Jan 28, 2022

BUY
$372.36 - $412.07 $73,727 - $81,589
198 Added 4.33%
4,768 $1.89 Million
Q1 2021

Jan 27, 2022

SELL
$357.26 - $392.57 $70,737 - $77,728
-198 Reduced 4.15%
4,570 $1.76 Million
Q4 2020

Feb 11, 2021

SELL
$319.05 - $363.32 $96,034 - $109,359
-301 Reduced 5.94%
4,768 $1.73 Million
Q3 2020

Nov 16, 2020

SELL
$280.08 - $347.78 $1.62 Million - $2.01 Million
-5,775 Reduced 53.26%
5,069 $1.71 Million
Q2 2020

Aug 11, 2020

BUY
$270.93 - $320.3 $1.68 Million - $1.98 Million
6,197 Added 133.35%
10,844 $3.08 Million
Q1 2020

May 14, 2020

BUY
$243.44 - $359.98 $1.13 Million - $1.67 Million
4,647 New
4,647 $1.28 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.57B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.